TELIF (Telescope Innovations) Total Receivables: $1.18 Mil (As of May. 2026)


TELIF Telescope Innovations Corp TELIF
31 GF Score
Price $0.51
GF Value $0.39
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Telescope Innovations Total Receivables?

Telescope Innovations TELIF -0.21% 31 Total Receivables is $1.18 Mil as of May. 2026. GuruFocus rates TELIF with a GF Score™ of 31/100 and a GF Value™ of $0.39 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Telescope Innovations's Total Receivables for the quarter that ended in May. 2026 was $1.18 Mil.

Telescope Innovations Total Receivables Related Terms

Telescope Innovations Total Receivables Historical Data

* Premium members only.

The historical data trend for Telescope Innovations's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telescope Innovations Total Receivables Chart

Telescope Innovations Annual Data
Trend Dec19 Dec20 Aug21 Aug22 Aug23 Aug24 Aug25
Total Receivables
Get a 7-Day Free Trial 0.05 0.56 0.35 1.21 0.32

Telescope Innovations Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.32 1.06 0.56 1.18
TELIF
31GF Score
Telescope Innovations Corp TELIF
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Telescope Innovations Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $1.18 Mil mean?
Telescope Innovations (TELIF) has a Total Receivables of $1.18 Mil as of May. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Telescope Innovations and its competitors.
Is Telescope Innovations' Total Receivables too high?
Telescope Innovations' current Total Receivables is $1.18 Mil. Overall, Telescope Innovations has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Telescope Innovations' Total Receivables compare to VRTX and REGN?
Telescope Innovations' Total Receivables of $1.18 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Telescope Innovations and its competitors. Telescope Innovations's current Total Receivables is $1.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telescope Innovations stock overvalued right now?
Based on GuruFocus' analysis, Telescope Innovations (TELIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.39, compared to a current price of $0.51 — trading 30.5% above its estimated fair value. The current Total Receivables is $1.18 Mil. Telescope Innovations' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Telescope Innovations (TELIF), the current Total Receivables is $1.18 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Telescope Innovations (TELIF) Overvalued in 2026?

Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued. The current stock price of $0.51 is trading 30.5% above its estimated GF Value™ of $0.39. GuruFocus considers Telescope Innovations to be Significantly Overvalued.

Key valuation signals for TELIF:

  • Total Receivables: $1.18 Mil
  • GF Value™: $0.39 vs. price of $0.51 (30.5% above fair value)
  • GF Score™: 31/100 with 1 warning sign

No single metric tells the full story. See the TELIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Telescope Innovations Business Description

Other Exchanges J4U:GermanyTELI:Canada
Address 2386 East Mall, Suite 301, Vancouver, BC, CAN, V6T 1Z3
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
31GF Score

Get the complete analysis for TELIF

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.51
Price
$0.39
GF Value